Contrarius Investment Management LTD Intellia Therapeutics, Inc. Transaction History
Contrarius Investment Management LTD
- $1.76 Billion
- Q3 2024
A detailed history of Contrarius Investment Management LTD transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Contrarius Investment Management LTD holds 2,047,218 shares of NTLA stock, worth $20.9 Million. This represents 2.39% of its overall portfolio holdings.
Number of Shares
2,047,218
Previous 1,915,410
6.88%
Holding current value
$20.9 Million
Previous $42.9 Million
1.86%
% of portfolio
2.39%
Previous 2.68%
Shares
6 transactions
Others Institutions Holding NTLA
# of Institutions
314Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$125 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$98.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$97.9 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$52.5 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$50.5 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $775M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...